0001829255-26-000001.txt : 20260831 0001829255-26-000001.hdr.sgml : 20260831 20260831125902 ACCESSION NUMBER: 0001829255-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260831 DATE AS OF CHANGE: 20260831 EFFECTIVENESS DATE: 20260831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Halia Therapeutics, Inc. CENTRAL INDEX KEY: 0001829255 ORGANIZATION NAME: EIN: 822679083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595921 FILM NUMBER: 261344912 BUSINESS ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: 801-753-5707 MAIL ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 D 1 primary_doc.xml X0708 D LIVE 0001829255 Halia Therapeutics, Inc. 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 801-842-1652 DELAWARE None None Corporation true Jeffrey Burton 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Executive Officer David Bearss 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Director David Checketts 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Director John S.K. Kauwe 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Director Gary B. Sabin 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Director Mary Beckerle 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Director Preston Campbell 3900 N. Traverse Mountain Blvd. Suite 100 Lehi UT UTAH 84043 Director Biotechnology Decline to Disclose 06b false 2026-08-17 false true true true Convertible Promissory Notes false 0 20000000 3486474 16513526 false 9 0 0 0 false Halia Therapeutics, Inc. Jeffrey Burton Jeffrey Burton Chief Financial Officer 2026-08-31